Gilbert Godin founded HLS Therapeutics, Inc. and HLS Therapeutics, Inc. Presently, Mr. Godin is Chief Executive Officer & Director at HLS Therapeutics, Inc.

Mr. Godin previously held the position of Chief Executive Officer of Duchesnay USA, Inc., President & Chief Executive Officer for MDS Pharma Services (Canada), President, Chief Operating Officer & Director at HLS Therapeutics, Inc. and Chief Operating Officer & Executive Vice President at Biovail Corp.

Gilbert Godin received an MBA from Concordia University, an undergraduate degree from the University of Sherbrooke and an MBA from John Molson School of Business.